SLC7A11 and bladder transitional cell carcinoma: Ferroptosis has been reported to inhibit tumorigenesis in different models, for example, lung cancer,[35] colorectal cancer,[36] and hepatocellular carcinoma,[37] which has potential as an innovative strategy for therapeutic targeting.[38] In the context of BLCA, few studies have elucidated the specific role of ferroptosis, particularly focusing on the xCT protein and the underlying mechanisms by which it affects disease progression.